Monitoring speech and language biomarkers in ADRD

“After years of developing automated methods to analyze speech and language markers in Alzheimer’s disease, it’s encouraging to see how crucial expressive communication is to both patients and caregivers. This insight will drive our research efforts forward, motivating us to align the definition of speech-based measurements and their validation processes using DiMe’s resources, to create solutions that truly matter in the field of patient care.” –—Dr Alexandra König | Chief Clinical Research Officer, ki: elements